Cysstic Fibrosis Essay

1917 Words4 Pages

Summary Cystic fibrosis [CF] is a chronic disease in which preventative treatment with nebulised antibiotics can reduce pulmonary exacerbations that otherwise require rescue therapy. However, adherence is low. Making adherence to maintenance treatment visible is a crucial step towards improving adherence. In this article, we discuss how adherence data can be used to support Quality Improvement in CF through behaviour change in both people with cystic fibrosis and their clinical teams. Keywords: Adherence, Cystic Fibrosis, Telemedicine The problem with treatment adherence in long-term conditions Adherence to medication among patients with long-term conditions is a major problem. An estimated 30-50% of medicines are not taken as recommended and adherence tends to decline after the first 6 months of treatment.[1, 2] Within the NHS, medication spend (£13-£14 billion per year) is the second highest cost after staff, yet it is estimated that within primary care at least £300 million worth of medicines are wasted each year due to poor adherence.[1] Other societal and economic costs of poor adherence include preventable hospital admissions, morbidity and mortality.[1] As the NHS faces increasing pressures from an ageing population, rising expectations and expensive technology, optimising medication use is an important agenda if NHS England is to improve population health and keep healthcare affordable.[3] Non-adherence is often discussed by healthcare professionals as an incomprehensible problem that only afflicts badly-behaved patients. In fact non-adherence affects us all: 80% of New Year’s resolutions fail,[4] not all members of the CF MDT take 30 minutes of exercise each day, eat 5-a-day and keep their BMI’s below 25. The insight that... ... middle of paper ... ...ven the smallest units to be understood which could never occur with outcomes such as BMI or FEV1.[10] Conclusion The CF community is a cohesive group of clinicians looking after a relatively small population within specialist clinics in which technology can be introduced across the whole population in a way that can be used to transform clinical practice. Improving adherence in CF offers the possibility of transforming CF care from unscheduled hospital based rescue that is disruptive to employment and schooling to scheduled, strategic and efficient community based prevention tailored to individuals’ needs. This will require optimal use of preventative therapy achieved by making adherence measures clearly visible within routine clinical practice combined with appropriate behaviour change strategies for clinicians and PWCF that can support ongoing quality improvement.

More about Cysstic Fibrosis Essay

Open Document